Correlation Between Posiflex Technology and Maxigen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Posiflex Technology and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Posiflex Technology and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Posiflex Technology and Maxigen Biotech, you can compare the effects of market volatilities on Posiflex Technology and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Posiflex Technology with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Posiflex Technology and Maxigen Biotech.

Diversification Opportunities for Posiflex Technology and Maxigen Biotech

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Posiflex and Maxigen is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Posiflex Technology and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and Posiflex Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Posiflex Technology are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of Posiflex Technology i.e., Posiflex Technology and Maxigen Biotech go up and down completely randomly.

Pair Corralation between Posiflex Technology and Maxigen Biotech

Assuming the 90 days trading horizon Posiflex Technology is expected to generate 9.46 times less return on investment than Maxigen Biotech. In addition to that, Posiflex Technology is 1.74 times more volatile than Maxigen Biotech. It trades about 0.01 of its total potential returns per unit of risk. Maxigen Biotech is currently generating about 0.23 per unit of volatility. If you would invest  4,840  in Maxigen Biotech on October 13, 2024 and sell it today you would earn a total of  330.00  from holding Maxigen Biotech or generate 6.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Posiflex Technology  vs.  Maxigen Biotech

 Performance 
       Timeline  
Posiflex Technology 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Posiflex Technology are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Posiflex Technology showed solid returns over the last few months and may actually be approaching a breakup point.
Maxigen Biotech 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Posiflex Technology and Maxigen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Posiflex Technology and Maxigen Biotech

The main advantage of trading using opposite Posiflex Technology and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Posiflex Technology position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.
The idea behind Posiflex Technology and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance